Guerbet S.A.
GBT.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$79.64M
Close$
$8.85
40.4% upside
Current Fair Value
40.4% upsideUndervalued by 40.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $79.64 Million |
|---|---|
| Enterprise Value | $421.44 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.59 |
| Beta | 0.97 |
| Outstanding Shares | 12,641,000 |
Return
| Return on Equity | 10.13% |
|---|---|
| Return on Assets | 3.85% |
| Return on Invested Capital | 10.89% |
Valuation & Multiples
| P/E Ratio | -0.58 |
|---|---|
| PEG | 0.76 |
| Price to Sales | 0.05 |
| Price to Book Ratio | 0.21 |
| Enterprise Value to Revenue | 0.26 |
| Enterprise Value to EBIT | 4.94 |
| Enterprise Value to Net Income | 10 |
| Total Debt to Enterprise | 0.93 |
| Debt to Equity | 0.99 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 16, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$379.20 M
Average shareholder expectationNext Earnings Call
Expected Date
March 24, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$382.66 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Guerbet S.A.
2,746 employees
CEO: Karim Boussebaa Guerbet S.A. is a medical technology company focused on the innovation and commercialization of contrast media products, specialized delivery systems, medical devices, and related solutions. Its comprehensive portfolio includes a range o...